Equine Mesenchymal Stromal Cells and Embryo-Derived Stem Cells Are Immune Privileged In Vitro
No immune response is reported following in vivo injection of allogeneic equine mesenchymal stem cells or embryo-derived stem cells into the equine tendon, which may be due to the cells’ immune privileged properties. Researchers investigated these properties to determine their potential for clinical application in other tissues. [Stem Cell Res Ther] Abstract|Full Article
Caveats of Mesenchymal Stem Cell Therapy in Solid Organ Transplantation
The authors address the potential pitfalls for the use of mesenchymal stem cells (MSCs) as a therapeutic agent to control alloimmune effects. The aim of this review is not to discourage investigators from clinical studies, but to raise awareness of the intrinsic risks of MSC therapy. [Transpl Int] Abstract
Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.
Recruit Top Talent: Reach more than 50,000 potential candidates by posting
your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!